Literature DB >> 3600729

Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions.

J M Leclair, J Freeman, B F Sullivan, C M Crowley, D A Goldmann.   

Abstract

To determine whether increased compliance with a policy of glove and gown isolation precautions could reduce the high rate of nosocomial respiratory syncytial virus (RSV) infection on an infant and toddler ward, we conducted a longitudinal intervention trial during three RSV seasons, from 1982 to 1985, with an intervention to increase compliance introduced midway through the second season. The risk of acquiring RSV infection in the hospital was adjusted for the intensity of nosocomial exposure to the virus by assigning each study week to one of five strata, defined by the proportion of hospital days on which virus was shed by children on the ward. Overall, 37 patients acquired nosocomial RSV infections during 7547 days at risk. The adjusted relative risk, comparing the infection rate in the period before the intervention (when compliance with isolation precautions was noted in only 38.5 percent of the observed patient contacts) with the infection rate in the postintervention period (when compliance more than doubled) was 2.9 (95 percent confidence interval, 1.5 to 5.7). Rates of nosocomial RSV infection increased linearly with increasing levels of exposure to patients shedding virus, but the rise in the infection rate with increasing exposure was less than one fourth as great (P less than 0.001) in the period after the intervention as it was before. We conclude that glove and gown precautions can substantially reduce the nosocomial transmission of RSV, particularly with increasing exposure to patients shedding the virus.

Entities:  

Mesh:

Year:  1987        PMID: 3600729     DOI: 10.1056/NEJM198708063170601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  46 in total

1.  Parenteral drug administration errors by nursing staff on an acute medical admissions ward during day duty.

Authors:  J Bruce; I Wong
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 3.  Significance of fomites in the spread of respiratory and enteric viral disease.

Authors:  Stephanie A Boone; Charles P Gerba
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

4.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 5.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 6.  Bronchiolitis. Origins and optimal management.

Authors:  M L Everard
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 7.  Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions.

Authors:  D A Goldmann
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

8.  Pandemic influenza (H1N1) 2009 and infection control controversies: Working with ongoing change.

Authors:  Dl Moore
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

9.  Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV).

Authors:  Joseph M Geskey; Neal J Thomas; Gretchen L Brummel
Journal:  Biologics       Date:  2007-03

Review 10.  Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review.

Authors:  Tom Jefferson; Chris Del Mar; Liz Dooley; Eliana Ferroni; Lubna A Al-Ansary; Ghada A Bawazeer; Mieke L van Driel; Ruth Foxlee; Alessandro Rivetti
Journal:  BMJ       Date:  2009-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.